TrialStem cell research & therapy2018

Safety analysis in patients with autoimmune disease receiving allogeneic mesenchymal stem cells infusion: a long-term retrospective study.

Jun Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.